1. Introduction {#sec1}
===============

Inflammation is a complex biological response of the immune system which is triggered by pathogens, damaged cells or toxic compounds ([@bib10]). Macrophages are tissue-resident or infiltrated immune cells critical in the initiation, maintenance, and resolution of acute inflammation ([@bib64]). Activated macrophages exert phagocytic activities and secrete inflammatory cytokines and mediators. Uncontrolled acute inflammation may become chronic, and is associated with many diseases, such as asthma, cancer, atherosclerosis, diabetes, and autoimmune diseases ([@bib10]). Emerging evidence suggests that cytokine storm syndrome, caused by an aggressive pro-inflammatory response in combination with an insufficient anti-inflammatory response, leads to high morbidity and mortality in COVID-19 (severe coronavirus disease 2019) ([@bib49]).

Microglial cells are the major brain-resident macrophages and mediate the immune surveillance and homeostasis in the central nervous system ([@bib54]). Several lines of evidence have highlighted the association between microglial activation and neuronal injury and neurodegeneration ([@bib45]). Microglia also play an important role in the neuropathic pain development and inhibiting microglial activation reduces hyperalgesia and allodynia ([@bib24]; [@bib70]). Thus, there is increasing interest in therapeutically targeting the inflammatory response and desperate hunt for agents blocking hyperinflammation ([@bib31]; [@bib49]; [@bib60]).

Nrf2 (NF-E2 p45-related factor 2) signaling is the major cellular defense to relieve oxidative and electrophilic stress ([@bib53]). Under oxidative stress, Nrf2-bound Keap1 (Kelch-like ECH-associated protein) is inactivated and, consequently, newly synthesized Nrf2 proteins bypass Keap1 and translocate into the nucleus, bind to the ARE (antioxidant response element) and drive the expression of Nrf2 target genes ([@bib27]). The Nrf2 target genes include antioxidant responsive genes, such as heme oxygenase-1 (HO-1) and glutamate cysteine ligase (GCL), and drug metabolism genes, such as NAD(P)H dehydrogenase, quinone 1 (NQO1). Small molecules that activate Nrf2 signaling are under active study for their potential to become anti-inflammatory and cancer preventive agents ([@bib69]). Plants are rich sources of Nrf2 activing phytochemicals; therefore, development of anti-inflammatory Nrf2 activators from plant extracts has attracted attention in biomedical field ([@bib1]; [@bib14]; [@bib68], [@bib67]).

*Vernonia patula* (Dryand.) Merr. (VP) is a folk medicine claimed to have the properties of antipyretic, detoxication, antibacterial, antiphlogistic, hypotention, blood stasis removal, hemostasis, expectoration, cough-relieving, antihepatitis and antitumor in Taiwan ([@bib41]). Its ethanol extract was reported to inhibit rat paw edema induced by carrageenan and histamine ([@bib22]). *Leucas chinensis* (Retz.) R. Brown (LC, also named as *L. mollissima* Wall.) is a herbal medicine widely available in Southeast Asia for reducing inflammatory symptoms ([@bib32]). The essential oil isolated from LC has antimicrobial, free radical scavenging and antioxidant activities ([@bib52]). These two herbs can be used alone or in combination with three other herbs, *Euonymus laxiflorus* Champ. ex Benth., *Justicia procumbens* L., and *Viola diffusa* Ging to produce "Five hông sàn", a traditional Taiwanese anti-inflammatory and analgesic decoction ([@bib9]; [@bib26]; [@bib36]).

RAW264.7 cells are macrophage cell line established from an ascites of a tumor induced by Abelson leukemia virus transformation in BALB/c mice ([@bib56]). BV2 cell line is generated by transformation of C57BL/6 mice microglial cells with v-raf/v-myc oncogene carrying retrovirus ([@bib5]). Both cell lines are suitable models for screening anti-inflammatory agents characterized by inhibiting lipopolysaccharide (LPS)-triggered pro-inflammatory cytokines and mediators ([@bib14]; [@bib66], [@bib67]).

The biologically active components of medicinal herbs are responsible for their efficacy. However, they usually consist of a complex mixture of phytochemicals and the active ingredient content is relatively low and hard to separate for identification. High-performance liquid chromatography with mass spectrometry (HPLC-MS) does not require extensive purification of chemical constituents and is becoming a popular choice for analysis of medicinal herbs, especially on micro- or trace-scale ([@bib34]; [@bib38]).

Most herbal medicines customarily are extracted with hot water. However, in preliminary experiments, we found that hot water extracts of *V. patula* (VP) and *L. chinensis* (LC) exhibited much lower anti-inflammatory activities than ethanol extracts in LPS-stimulated RAW264.7 cells and BV2 cells. Therefore, ethanol was used for extracting the bioactive components to maximize anti-inflammatory activities. The possible involvement of Nrf2-ARE pathways in their anti-inflammatory and antioxidant activities will also be investigated. The active chemical components, with special focus on phenolics and triterpenes, will be identified using HPLC-MS with electrospray ionization.

2. Materials and methods {#sec2}
========================

2.1. Materials {#sec2.1}
--------------

*V. patula* (VP) and *L. chinensis* (LC) were purchased from Tien-Yi Herb, Yunlin, Taiwan in July 2017 and authenticated by Dr. J. J. Yang of Chia Nan University of Pharmacy and Science. They were planted in the herbary of Department of Biotechnology. The voucher specimens CN5391070501 for VP and CN5230190112 for LC, were deposited in the Traditional Materia Medica Applied Technology Development Center, Chia Nan University of Pharmacy and Science.

Griess reagent, MTT (3-(4,5-dimethylthiazol-2-yl)- 2,5-diphenyl tetrazolium bromide), lipopolysaccharide (LPS) from *Escherichia coli* O111:B4, polymyxin B sulfate (PMB), sodium nitrite, RIPA buffer, reference compounds used in HPLC-MS and other chemicals were purchased from Sigma-Aldrich Co. (St. Louis, MO), unless otherwise indicated.

2.2. Ethanol extraction {#sec2.2}
-----------------------

The aerial parts of VP and LC were air-dried and cut into small pieces. 300 g sample/each was extracted by reflux in 1.5 L 95% ethanol at 50 °C. After extraction three times, the extraction of ethanol-reflux was combined. Subsequently, the extract solution was filtered and then evaporated to dryness on rotary evaporator. The dried extracts were kept at 4 °C. Before each experiment, the extracts were dissolved in 95% ethanol and sonicated for 2 min at room temperature.

2.3. Culture of RAW264.7 and BV2 cells {#sec2.3}
--------------------------------------

RAW264.7 cells were purchased from the Bioresource Collection and Research Center (Hsinchu, Taiwan) and cultured in Dulbecco\'s modified Eagle\'s medium (DMEM, Thermo Fisher Scientific Inc.) with 10% fetal bovine serum (GE Life Sciences), 2 mM glutamine, 1% nonessential amino acid, 1 mM pyruvate, 100 U/mL penicillin, and 100 μg/mL streptomycin (Thermo Fisher Scientific Inc.).

BV2 cells was kindly provided by Professor Shun-Fen Tzeng (National Cheng Kung University) and cultured in Dulbecco\'s Modified Eagle Medium/Nutrient Mixture F-12 (DMEM/F12, Thermo Fisher Scientific Inc.) with 10% fetal bovine serum, 100 U/mL penicillin, and 100 μg/mL streptomycin. Both cell lines were maintained in a humidified incubator at 37 °C in 5% CO~2~.

2.4. Measurement of nitric oxide, interleukin-6 and cell viability {#sec2.4}
------------------------------------------------------------------

Both cell lines (1 × 10^5^/well) were pretreated with antibiotic polymyxin B (PMB) or indicated extract for 30 min prior to LPS treatment in 96-well plates. After 20 h, the culture supernatants were collected for the determination of nitrite (NO~2^−^~). Nitrite is the primary, stable and nonvolatile breakdown products of nitric oxide (NO). It was analyzed by formation of a red pink azo upon treatment with the Griess reagent and measured spectrophotometrically at 550 nm against a nitrite standard curve ([@bib21]). Interleukin-6 (IL-6) released in the supernatant was measured after LPS treatment for 16 h by Mouse IL-6 ELISA Set (BD Biosciences, San Diego, CA) according to the manufacturer\'s instructions.

Cell viability in the cultured well was analyzed by treatment with 0.5% MTT (in serum-free cultured medium) and incubated for 3 h in the incubator. MTT solution was then removed and the formazan crystals produced were dissolved by DMSO and absorbance was measured spectrophotometrically at 550 nm. ([@bib8]).

2.5. RNA extraction and reverse transcription real-time PCR {#sec2.5}
-----------------------------------------------------------

RNA was extracted from BV2 and RAW264.7 cells with the Illustra RNA Spin Mini RNA Isolation Kit (GE Healthcare). The reverse transcription was performed using a High-Capacity cDNA Archive kit (Thermo Fisher Scientific). Quantitative PCR was then performed using a Power SYBR Green PCR Master Mix (Thermo Fisher Scientific) in a total volume of 20 μL that contained 0.4 μM of each primer ([Table 1](#tbl1){ref-type="table"} ). Thermal cycling was performed at 95 °C for 2 min, 40 cycles at 94 °C for 15 s, and 60 °C for 60 s (ABI StepOne Real Time PCR System). The relative mRNA expression was normalized with β-actin expression and then calculated by the 2^−ΔΔ*C*T^ method. Specificity verification was done by melting curve.Table 1Primer pairs used in RT-Q-PCR.Table 1GenePrimersAmplicon (bp)*β-actin*GGCTGTATTCCCCTCCATCG154CCAGTTGGTAACAATGCCATGT*iNOS*GTTCTCAGCCCAACAATACAAGA127GTGGACGGGTCGATGTCAC*IL-6*TAGTCCTTCCTACCCCAATTTCC153CGCACTAGGTTTGCCGAGTA*IL-1β*TTCAGGCAGGCAGTATCACTC\
GAAGGTCCACGGGAAAGACAC75*CCL2*TTAAAAACCTGGATCGGAACCAA121GCATTAGCTTCAGATTTACGGGT*HO-1*AAGCCGAGAATGCTGAGTTCA100GCCGTGTAGATATGGTACAAGGA*GCLM*AAGCCCAGGATTGGGTGCCG141GGTCGGTGAGCTGTGGGTGT*NQO1*AGGATGGGAGGTACTCGAATC127TGCTAGAGATGACTCGGAAGG

2.6. Western blotting analysis {#sec2.6}
------------------------------

Cell lysates and nuclear extracts were prepared using RIPA lysis buffer and nuclear extraction kit (Cayman), respectively. The protein concentration was determined by the Bradford method (Bio-Rad Laboratories, Hercules, CA, USA), using bovine serum albumin as a standard reference.

Equal amounts of protein were subjected to separate on 8--12% SDS-PAGE. Following electrophoretic separation, the proteins were transferred to polyvinylidene difluoride (PVDF) membranes (Hybond-P, GE Healthcare) by CAPS buffer (10 mM, pH 10.5, 10% methanol) at 20 V overnight at 4 °C. The membranes were blocked in freshly made blocking buffer (5% skim milk in PBS with 0.05% Tween 20, pH 7.4) for 8 h at room temperature and then probed with specific primary antibody ([Table 2](#tbl2){ref-type="table"} ) overnight at 4 °C. After rinsing the membrane to remove unbound primary antibody, the membrane was exposed to suitable horseradish peroxidase (HRP)-conjugated secondary antibody (Jackson ImmunoResearch, West Grove, PA) for 1 h. The antigen-antibody reaction was detected using enhanced chemiluminescence detection (GE Healthcare).Table 2Primary antibodies used in Western blotting.Table 2AntibodyCompanyCatalog NumberNrf2Cell Signaling12721HDAC2GeneTex112957NOSCell Signaling2977HO-1StressgenSPA-895β-actinProteintech20536-1-AP

2.7. DPPH scavenging capacities {#sec2.7}
-------------------------------

DPPH (2,2-Diphenyl-1-(2,4,6-trinitrophenyl) hydrazyl, 0.1 mM in methanol) scavenging capacity was analyzed according to the literature ([@bib59]). IC~50~ was calculated from dose-inhibition curve.

2.8. Assay of Trolox equivalent antioxidant capacity (TEAC) {#sec2.8}
-----------------------------------------------------------

The pre-formed radical monocation of 2,2′-azinobis-(3-ethylbenzothiazoline- 6-sulfonic acid) (ABTS•^+^) is generated by ABTS/K~2~S~2~O~8~ prior to addition of tested antioxidant. The results of ABTS•^+^ radical assays were presented as Trolox (6-hydroxy-2,5,7,8- tetramethychroman-2-carboxylic acid) equivalent antioxidant capacity (TEAC) using Trolox as reference standard. To calculate the TEAC, the slope of concentration-inhibition curve for tested extract is divided by that for Trolox and the results are expressed minigrams of Trolox equivalent per gram of dry weight (mg·TE/g·dw) ([@bib57]).

2.9. Folin-Ciocalteu assay {#sec2.9}
--------------------------

Total phenolic content was determined by the slightly modified Folin-Ciocalteu (F--C) assay ([@bib18]). Absorbance was read at 620 nm and the results are expressed as minigrams of gallic acid equivalent per gram of dry weight (mg·GAE/g·dw).

2.10. Identification of bioactive compounds by HPLC-ESI-MS (high-performance liquid chromatography electrospray ionization mass spectrometry) {#sec2.10}
---------------------------------------------------------------------------------------------------------------------------------------------

VP and LC extracts were subjected to 0.45 μm filtration before analyzed by HPLC-MS using Shimadzu LCMS-8050 triple quadrupole mass spectrometry with electrospray ionization. The column for the HPLC system was a Shim-pack GIS C18 (C18, 3 μm, 4.6 × 250 mm, Shimadzu) at 30 °C. The mobile phase was consisted of methanol (solvent A) and 5 mM ammonium formate (solvent B) in a linear gradient (from 15 to 95% of A) for 45 min with a flow rate of 0.8 mL/min. In all analyses, the injected volume was 3 μL.

For identification of the phytochemicals, authentic reference phenolic compounds (morin, fisetin, quercetin, kaempferol, apigenin, luteolin, chrysoeriol, dihydroxyflavone) and triterpenes (betulinic acid and oleanolic acid) were analyzed in the same conditions as described above.

2.11. Statistical analysis {#sec2.11}
--------------------------

All experiments were repeated at least three times, and the values were expressed as the mean ± SD. The results were analyzed using One-way ANOVA with Dunnett\'s post hoc test, and a *p* value \< 0.05 was considered statistically significant.

3. Results {#sec3}
==========

3.1. Anti-inflammatory activities of *V. patula* (VP) and *L. chinensis* (LC) {#sec3.1}
-----------------------------------------------------------------------------

Anti-inflammatory activities of ethanol extracts of VP and LC were first measured by inhibition of nitric oxide (NO) production in LPS-treated RAW264.7 and BV2 cells. Nitric oxide (NO) is a signaling molecule that is involved in the pathogenesis of inflammatory disorders and therefore represents an important therapeutic target ([@bib7]; [@bib58]). [Fig. 1](#fig1){ref-type="fig"} a shows that RAW264.7 cells dramatically increased NO production (from unstimulated 2.37 ± 0.35 μM to 29.53 ± 0.35 μM), 20 h after treatment with LPS (10 ng/mL). Polymyxin B (PMB), a cyclic amphipathic peptide antibiotic binding to LPS ([@bib16]), was used as a control. PMB (10 μg/mL) completely blocked LPS-induced NO production. In comparison, VP and LC (0.05--0.2 mg/mL) significantly inhibited NO production by 32%--84% in a dose-dependent manner. To investigate the NO-lowered effect was not due to direct cytotoxic activity, MTT assay was employed. [Fig. 1](#fig1){ref-type="fig"}b shows VP (0.2 mg/mL) exhibited about 5% cytotoxicity, while the other treatments did not exert detectable cytotoxicity.Fig. 1Ethanol extracts of *V. patula* (VP) and *L. chinensis* (LC) inhibited nitric oxide production in LPS-induced RAW264.7 cells (**a** and **b**) and BV2 cells (**c and d**). Cells were pre-treated for 0.5 h with polymyxin B (PMB, 10 μg/mL), vehicle (0.1% ethanol), or indicated concentration of VP or LC, and then stimulated with LPS (10 ng/mL) for 20 h. The nitrite concentration in supernatant was determined by the Griess reagent (**a and c)**. The cell viability was analyzed by MTT assay **(b and d)**. Data are represented as the mean ± SD (n = 3). Statistical differences are presented \*\*, *p* \< 0.01 compared with the vehicle control (without LPS) and \#*p* \< 0.05; \#\#, *p* \< 0.01 compared with the LPS-treated vehicle.Fig. 1

LPS-mediated microglia activation and NO production plays a key role in the development of neuroinflammation and neuropathic pain ([@bib17]). Therefore, we further investigated the anti-NO effects of VP and LC in LPS-treated BV2 microglia. As shown in [Fig. 1](#fig1){ref-type="fig"}c, BV2 cells exhibited increased production of NO (from 3.12 ± 0.58 μM to 46.84 ± 1.35 μM), 20 h after treatment with LPS (10 ng/mL). VP and LC (0.05--0.2 mg/mL) dose-dependently inhibited LPS-induced NO production in BV2 cells.

[Fig. 1](#fig1){ref-type="fig"}d shows that LPS (10 ng/mL) caused significant BV2 cell death, as compared with the vehicle control (0.1% ethanol), supporting the notion that LPS causes apoptosis in microglia ([@bib43]). PMB (10 μg/mL) completely blocked LPS-caused cell death. VP (0.1 mg/mL) and LC (0.05 mg/mL) slightly mitigated LPS-mediated cytotoxicity; however, higher concentration of LC (0.2 mg/mL) resulted in enhanced cytotoxicity.

Interleukin-6 (IL-6) is a soluble mediator with a pleiotropic effect on inflammation, immune response, and hematopoiesis. Dysregulated synthesis of IL-6 has being implicated in the pathogenesis/pathophysiology of numerous inflammatory diseases ([@bib61]). We thus further studied the inhibitory activities of VP and LC, at effective and non-toxic concentrations (0.05 and 0.1 mg/mL), on LPS-mediated IL-6 production in RAW264.7 and BV2 cells. We found that LPS induced high level of IL-6 production in RAW274.7 cells and BV2 cells, and VP and LC (0.05 and 0.1 mg/mL) could inhibit LPS-stimulated IL-6 production significantly ([Fig. 2](#fig2){ref-type="fig"} ). The dose-dependent effects of VP and LC were more pronounced in BV2 cells than in RAW264.7 cells.Fig. 2Effects of VP and LC on the production of IL-6 in RAW264.7 cells (a) and BV2 cells (b). Cells were pre-treated with indicated reagent for 30 min followed by LPS treatment for 16 h. The supernatant were collected for IL-6 assay, as described in Materials and Methods. Data are represented as the mean ± SD (n = 3). Statistical differences are presented \*\*, *p* \< 0.01 compared with the vehicle control (without LPS) and \#*p* \< 0.05; \#\#, *p* \< 0.01 compared with the LPS-treated vehicle.Fig. 2

3.2. Effects of VP and LC on the mRNA expression of the pro-inflammatory genes {#sec3.2}
------------------------------------------------------------------------------

We further investigated how VP and LC affect pro-inflammatory gene expression in LPS-treated BV2 cells. Production of NO is produced from L-arginine via the action of NO synthase (NOS). Inducible NO synthase (iNOS) is induced by LPS in microglia. We found that LPS (10 ng/mL) significantly upregulated iNOS transcript by 1513-fold in BV2 cells after 4 h treatment ([Fig. 3](#fig3){ref-type="fig"} a). VP and LC (0.05 and 0.1 mg/mL) dose-dependently attenuated iNOS mRNA expression. Western blot analysis ([Fig. 4](#fig4){ref-type="fig"} b) shows that LPS (10 ng/mL) dramatically increased iNOS protein expression after 16 h treatment and VP and LC (0.05 and 0.1 mg/mL) attenuated LPS-mediated iNOS protein expression in dose-dependent manners in parallel to their anti-NO potencies.Fig. 3Effects of VP and LC on the mRNA expression of pro-inflammatory genes in BV2 cells. BV2 cells were pre-treated with indicated reagent for 30 min followed by LPS treatment for 4 h in 6-well plates. RNA preparation and RT-Q-PCR were performed as described in Materials and Methods. Data are represented as the mean ± SD (n = 3). Statistical differences are presented \*\*, *p* \< 0.01 compared with the vehicle control (without LPS) and \#*p* \< 0.05; \#\#, *p* \< 0.01 compared with the LPS-treated vehicle.Fig. 3Fig. 4VP and LC activated Nrf2-ARE pathway and inhibited iNOS protein expression in BV2 cells. **(a)** BV2 cells were pretreated with indicated reagent for 30 min followed by LPS treatment for 2 h. The levels of Nrf2 and HDAC2 were determined from nuclear extract by Western blotting. **(b)** Total cell lysate was prepared 16 h after LPS insult and levels of iNOS and HO-1 expression were determined by Western blotting. **(c**--**e)** HO-1, GCLM and NQO-1 mRNA levels were determined 4 h after LPS treatment by RT-Q-PCR. Data are represented as the mean ± SD (n = 3). Statistical differences are presented \*, *p* \< 0.05 compared with the vehicle control (without LPS) and \#, *p* \< 0.05; \#\#, *p* \< 0.01 compared with the LPS-treated vehicle.Fig. 4

The expression and degradation of IL-6 mRNA is regulated transcriptionally and post-transcriptionally by several transcription factors, proteins and microRNAs ([@bib61]). We found that LPS strongly stimulated IL-6 mRNA expression by 3012-fold in BV2 cells after 4 h incubation. VP and LC at 0.1 mg/mL, but not at lower concentrations, could significantly reduce LPS-upregulated IL-6 mRNA level ([Fig. 3](#fig3){ref-type="fig"}b). This indicates that the reduction of IL-6 production by VP and LC in BV2 cells (shown in [Fig. 2](#fig2){ref-type="fig"}b) might occur via both transcriptional and translational inhibition.

Interleukin-1 (IL-1) mediates highly inflammatory responses via two cytokine species, IL-1α and IL-1β ([@bib47]). IL-1β mRNA levels rise rapidly and transiently upon LPS stimulation due to short mRNA half-life or the action of microRNA ([@bib13]). [Fig. 3](#fig3){ref-type="fig"}c shows that LPS (10 ng/mL) caused a 187-fold increase in IL-1β mRNA expression in BV2 cells after 4 h treatment. VP and LC (0.05 and 0.1 mg/mL) markedly down-regulated LPS-stimulated IL-1β mRNA production.

The main activity of CCL2 (CC chemokine ligand 2)/MCP-1 (monocyte chemoattractant protein-1) is to recruit monocytes, memory T cells, and dendritic cells to the sites of inflammation during inflammation ([@bib6]). A 23-fold induction of CCL2/MCP-1 mRNA expression was observed 4 h after LPS (10 ng/mL) treatment, and co-treatment with VP (0.025--0.1 mg/mL) and LC (0.1 mg/mL) inhibited its expression ([Fig. 3](#fig3){ref-type="fig"}d).

From the above data, we conclude that LPS-mediated pro-inflammatory mRNA overexpression, including enzyme: iNOS, cytokines: IL-6 and IL-1β, and chemokine: CCL2/MCP-1, were attenuated by VP and LC dose-dependently in BV2 cells.

In comparison, VP and LC exhibited much weaker efficacy in inhibition of LPS-induced iNOS and IL-6 mRNA expression in RAW264.7 cells than in BV2 cells ([Supplemental Fig. 1](#appsec1){ref-type="sec"}). These results indicate that downregulation of NO and IL-6 production by VP and LC possibly occurs at steps other than regulating mRNA levels in RAW264.7 cells.

3.3. Direct antioxidant capacities of VP and LC {#sec3.3}
-----------------------------------------------

It is well-known that most of the anti-inflammatory herbal extracts also exert antioxidant activities ([@bib11]; [@bib14]; [@bib22]; [@bib51]). Direct antioxidant capacity can be defined as scavenging free radical by donating hydrogen or electrons. On the other hand, the indirect antioxidant capacity is involved in mitigating the oxidative stress via the expression of Phase II detoxifying and antioxidant genes ([@bib15]). We first used DPPH and ABTS•^+^ quenching activities as well as total phenolic content by Folin-Ciocalteu (F--C) assay to analyze the direct antioxidant activities of VP and LC. DPPH and ABTS•^+^ quenching activities are considered as mixed electron transfer and hydrogen atom transfer assays ([@bib3]); while F--C assay is normally described as electron transfer assay ([@bib18]). [Table 3](#tbl3){ref-type="table"} shows that VP had about twice higher phenolic content and exerted three-to four-fold stronger DPPH and ABTS•^+^ bleaching activities than LC. The differences in antioxidant potentials may result from the fact that F--C measures only the hydrophilic antioxidants, DPPH detects only those soluble in organic solvents, while ABTS•^+^ determines both hydrophilic and hydrophobic samples ([@bib2]; [@bib12]).Table 3Direct antioxidant capacities of VP and LC.Table 3SamplesIC~50~ for DPPH Scavenging (μg/mL)[a](#tbl3fna){ref-type="table-fn"}TEAC (mg·TE/g·dw)[b](#tbl3fnb){ref-type="table-fn"}Total Phenolic Content (mg·GAE/g·dw)[c](#tbl3fnc){ref-type="table-fn"}VP20.95 ± 1.43190 ± 478 ± 4LC60.27 ± 1.2350 ± 241 ± 4α-tocopherol10.92 ± 2.58-[d](#tbl3fnd){ref-type="table-fn"}-[d](#tbl3fnd){ref-type="table-fn"}[^2][^3][^4][^5][^6]

3.4. VP and LC induce Nrf2 activation and phase II gene expression {#sec3.4}
------------------------------------------------------------------

We further investigated indirect antioxidant capacities of VP and LC by measuring Nrf2 transcription factor activation in BV2 cells. Western blot analysis was employed to determine nuclear Nrf2 protein level. The ubiquitously expressed histone deacetylase 2 (HDAC2) was used as a loading control. [Fig. 4](#fig4){ref-type="fig"}a shows that LPS (10 ng/mL) induced Nrf2 translocation into nucleus after 2 h insult. Both VP and LC enhanced Nrf2 activation dose-dependently, and in parallel to the direct antioxidant activities shown above, VP activated Nrf2 more prominently than LC.

Heme oxygenase (HO)-1 is one of the Nrf2-driven genes and exhibits antioxidant and anti-inflammatory properties ([@bib29]; [@bib35]; [@bib40]; [@bib62]). Similar to those found for Nrf2 activation, LPS slightly induced HO-1 protein expression after 16 h treatment, while co-treatment with VP and LC enhanced HO-1 upregulation dose-dependently. VP was more potent than LC in HO-1 protein induction ([Fig. 4](#fig4){ref-type="fig"}b). Resembling to HO-1 protein expression, LPS only slightly induced HO-1 mRNA expression by 1.56-fold after 4 h treatment, while co-treatment with 0.1 mg/mL VP and LC enhanced the HO-1 mRNA expression by 12.0- and 8.2-fold, respectively ([Fig. 4](#fig4){ref-type="fig"}c).

In addition to HO-1, Nrf2 also induces other Phase II enzymes, such as glutamate cysteine ligase modifier subunit (GCLM) and NAD(P)H quinone dehydrogenase 1 (NQO1) ([@bib46]). [Fig. 4](#fig4){ref-type="fig"}d and e shows that LPS alone did not significantly induce GCLM or NQO1 transcription; however, co-treatment with VP or LC (0.05 and 0.1 mg/mL) markedly stimulated GCLM and NQO1 mRNA expression in a dose-dependent manner. VP and LC also exerted HO-1 and NQO1 gene induction in RAW264.7 cells ([Supplemental Fig. 2](#appsec1){ref-type="sec"}). This observation suggests that VP and LC activate Nrf2-ARE signaling pathway so as to repress inflammatory response.

3.5. Determination of phenolic and triterpene compounds in VP and LC {#sec3.5}
--------------------------------------------------------------------

VP and LC may contain lots of flavonoids and triterpenes with similar structures and polarities. We therefore used HPLC-MS to identify their bioactive composition without extensive purification. The identification of chemical constituents was based on their mass-to-charge ratio (*m/z*) and direct retention time matching with authentic references. Total ion chromatograms (TIC) by negative ion mode electrospray ionization mass spectrometry (ESI/MS) of VP and LC were shown in [Fig. 5](#fig5){ref-type="fig"} a. Lots of peaks were separated and the strongest peaks were observed at retention time about 17.0 min and peak clustered between 26 and 27.5 min. The peaks with the same *m/z* as references were further extracted from TIC as extracted ion chromatogram (XIC). Three flavonoids, apigenin (1), luteolin (2), and chryseriol (luteolin 3′-methyl ether) (3), were identified in both VP and LC via comparing with 8 authentic references ([Fig. 5](#fig5){ref-type="fig"}b and c and [Table 4](#tbl4){ref-type="table"} ). All three identified flavonoids were at retention time around 17 min. Compound x, likely to be diosmetin (luteolin 4′-methyl ether) or other isomer, was also detected at *m/z* 299.25 at 16.65 min for VP.Fig. 5Total ion chromatograms (TIC) and extracted ion chromatograms (XIC) obtained by HPLC-MS separation of VP and LC. **(a)** TIC scan of VP and LC. The \"\*\" labeled the strongest peak. **(b)** XIC of VP. **(c)** XIC of LC. The HPLC-MS procedure was carried out as described in Materials and Methods.Fig. 5Table 4Identification of phytochemicals in VP and LC by HPLC-MS.Table 4Authentic ReferenceRetention\
Time (min)\[M+H\]^+^*m/z*\[M-H\]^−^*m/z*VP (min)LC (min)Morin9.73303.23301.23ND[b](#tbl4fnb){ref-type="table-fn"}ND[b](#tbl4fnb){ref-type="table-fn"}Fisetin12.88287.24285.24ND[b](#tbl4fnb){ref-type="table-fn"}ND[b](#tbl4fnb){ref-type="table-fn"}Quercetin14.54303.23301.23ND[b](#tbl4fnb){ref-type="table-fn"}ND[b](#tbl4fnb){ref-type="table-fn"}Kaempferol16.58287.24285.24ND[b](#tbl4fnb){ref-type="table-fn"}ND[b](#tbl4fnb){ref-type="table-fn"}Apigenin (1)16.85271.05269.0516.8616.85Luteolin (2)16.98-[a](#tbl4fna){ref-type="table-fn"}285.2416.9516.98Chrysoeriol (3)17.09301.26299.2617.0017.03Dihydroxyflavone20.32255.24253.24ND[b](#tbl4fnb){ref-type="table-fn"}ND[b](#tbl4fnb){ref-type="table-fn"}Betulinic acid (4)27.06-[a](#tbl4fna){ref-type="table-fn"}455.7027.0327.08Oleanolic acid (5)27.27-[a](#tbl4fna){ref-type="table-fn"}455.70ND[b](#tbl4fnb){ref-type="table-fn"}27.24[^7][^8]

Betulinic (BA) and oleanolic (OA) acids are triterpenic acids with multiple therapeutic effects; therefore *m/z* 455.7 was monitored to identify these two compounds. [Fig. 5](#fig5){ref-type="fig"}b and c show that BA was identified in VP, while BA and OA were in LC, and both were at retention time about 27 min. Combination of TIC and XIC data indicate that the identified flavonoids and triterpenic acids may be the major constituents of VP and LC.

4. Discussion {#sec4}
=============

In this research, we report the anti-inflammatory and antioxidant activities and mechanisms of ethanol extracts of *V. patula* (VP) and *L. chinensis* (LC). They inhibited NO and IL-6 production in LPS-treated RAW264.7 macrophages and BV2 mircoglia. They also inhibited LPS-mediated expression of pro-inflammatory cytokine and pro-inflammatory chemokine, IL-1β and CCL2/MCP-1, in a dose-dependent manner in BV2 cells.

It is well-documented that lots of natural antioxidants also serve as anti-inflammatory agents ([@bib4]). In general, direct antioxidants are redox active, short-lived small molecules that directly scavenge reactive oxygen and/or nitrogen species ([@bib15]). On the other hand, indirect antioxidants induce Keap1/Nrf2/ARE pathway and target Phase II gene expression resulting in increased antioxidant capacity and long-lived protective effect compared to direct antioxidants ([@bib15]). We found that VP showed stronger direct antioxidant capacities by exhibiting potent DPPH and ABTS•^+^ free radical scavenging activities and had higher total phenolic contents as compared with LC. In parallel to the direct antioxidant capacity, VP induced Nrf2 activation and Phase II genes expression stronger than LC.

Nrf2 activation is crucial in modulating redox homeostasis and regulating inflammatory conditions via the induction of many stress responsive and cytoprotective enzymes including HO-1, GCLM and NQO1 ([@bib30]). It has been reported that HO-1 inhibited LPS-mediated inflammatory responses in RAW264.7 and BV2 cells ([@bib33]; [@bib67]). HO catalyzes the degradation of heme to biliverdin/bilirubin, ferrous iron, and carbon monoxide. Carbon monoxide acts as an inhibitor of the NF-κB pathway which leads to the decreased expression of pro-inflammatory cytokines, while bilirubin also acts as antioxidant ([@bib1]).

GCL catalyzes the first and rate-limiting step in *de novo* GSH synthesis. GCL is composed of two subunits, the catalytic subunit GCLC and the modifier subunit GCLM. GSH is not only important as an antioxidant and inhibitor of inflammation but also as a signaling molecule for redox regulation ([@bib20]). NQO1 catalyzes the reduction of quinones to hydroquinones and is a key component of cellular antioxidant defense system. Several reports establish an inverse correlation between NQO1 and NF-κB activation ([@bib25]). Current study demonstrates that both VP and LC significantly induce the expression of HO-1, GCLM and NQO1, and the upregulation might be responsible for the repression of pro-inflammatory gene expression.

Previously, four flavones, luteolin, tricin, luteolin 4-*O*-β-D-glucoside and luteolin 7-*O*-β-D-glucoside, four caffeoylquinates, 3,4-dicaffeoylquinic acid, 4,5-dicaffeoylquinic acid, ethyl 3,4-dicaffeoylquinate and chlorogenic acid, as well as esculetin, and two catechols, caffeic acid and protocatechuic acid have been identified from VP ([@bib42]). In this report, we further reported the presence of apigenin (1), chryseriol (3), and betulinic acid (BA) (4) in VP ([Fig. 6](#fig6){ref-type="fig"} ).Fig. 6Chemical structures of compounds identified in VP and LC. Apigenin (1), luteolin (2), chryseriol (3), betulinic acid (4) and oleanolic acid (5) were found in LC; while all except (5) were in VP.Fig. 6

It was reported that there were eight compounds: oleanolic acid 3-acetate, apigenin, apigenin-7-*O*-β-D- (6″-*p*-coumaroyl)glucoside, cirsimaritin (5,4′-dihydroxy-6,7-dimethoxyflavone), mixture of β-sitosterol and stigmasterol, and mixture of β-sitosterol-3-*O*-β-D-glucoside and stigmasterol-3-*O*-β-D-glucoside in the methanolic extract of *L. chinensis* ([@bib32]). In this report, luteolin (2), chryseriol (3), BA (4), and oleanolic acid (OA) (5) were further identified from LC ([Fig. 6](#fig6){ref-type="fig"}).

It was reported that lots of phytochemicals serve as Nrf2 activators and can be classified into several distinct classes ([@bib46]). We have reported previously that apigenin and luteolin activated Phase II gene expression and protected PC12 cells from oxidative stress ([@bib23]; [@bib39]; [@bib68]). Both compounds have been identified as strong antioxidant and anti-inflammatory flavonoids in various studies ([@bib19]; [@bib37]; [@bib66], [@bib65]). Chrysoeriol, 3′-*O*-methyl derivative of luteolin, has been shown to induce Nrf2 activation, HO-1 expression and inhibit ROS expression in LPS-mediated RAW264.7 cells ([@bib55]). Here we found that both VP and LC contain these three flavonoids, which may be in part responsible for their Nrf2 activation, antioxidant and anti-inflammatory activities.

Terpenoids form a large and structurally diverse family of natural compounds based on five-carbon isoprene units. BA is widely present in medicinal plants and has been reported to have various biological activities, such as antitumor, anti-bacterial and anti-inflammatory effects ([@bib71](). Its anti-inflammatory activity has been reported associated with HO-1 expression via Nrf2 signaling pathways ([@bib28]). In this report we found for the first time that both VP and LC contain BA, which may be one of Nrf2 activing constituents and play important role in their anti-inflammatory activities.

OA is a natural triterpenoid widely present in anti-inflammatory and hepatoprotective Chinese medicines ([@bib66]). It has been reported to activate Nrf2 and antioxidant gene expression ([@bib44]; [@bib63]). In this report we found LC, but not VP, contained OA.

In conclusion, anti-inflammatory and antioxidant activities of VP and LC may be in great part attributed to these identified Nrf2 activators, which induce expression of Phase II enzymes and attenuate transcriptional upregulation of proinflammatory genes. We realized our studies were found only on the *in vitro* effects, the anti-inflammatory and antioxidant effects of VP and LC in animal and human studies warrant further investigation.

5. Conclusions {#sec5}
==============

The ethanol extracts of *V. patula* (VP) and *L. chinensis* (LC) inhibited LPS-induced NO and IL-6 production in both RAW264.7 and BV2 cells. VP and LC also suppressed iNOS, IL-6, IL-1β and CCL2 expression. VP had stronger DPPH and ABTS•^+^ bleaching activity and activated greater Nrf2/ARE signaling than LC. Five known compounds: apigenin (1), luteolin (2), chryseriol (3), betulinic acid (4) and oleanolic acid (5) were found in LC; while compounds (1) to (4) were identified in VP by HPLC-MS. The anti-inflammatory and antioxidant effects of VP and LC may be attributed, at least in part, to these identified Nrf2 activating phytochemicals.
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[^1]: These authors contributed equally to this work.

[^2]: Data are represented as the mean ± SD (*n* = 3).

[^3]: IC~50~ for DPPH scavenging: concentration (in μg/mL) necessary for reduction 50% DPPH radical.

[^4]: TEAC: minigrams of Trolox equivalent (TE) per gram of extract dry weight.

[^5]: Total Phenolic Content: minigrams of gallic acid equivalent (GAE) per gram of extract dry weight.

[^6]: did not measure.

[^7]: did not measure.

[^8]: ND: not detected.
